Penn State Health purchases second ViewRay MRIdian linac

Over 600 Total Lots Up For Auction at Two Locations - OK 04/26, CA 04/30

Penn State Health purchases second ViewRay MRIdian linac

Press releases may be edited for formatting or style | February 11, 2021 Rad Oncology
CLEVELAND, Feb. 11, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Penn State Health has purchased a second MRIdian Linac joining other pioneering institutions from around the globe investing in multiple MRIdian systems. Penn State Health's first MRIdian Linac will be installed at the Penn State Health Milton S. Hershey Medical Center.

Penn State Health is a nationally ranked premier health care provider on the east coast and a world-leading medical research institution. Penn State Health approaches cancer treatment with a comprehensive, integrated program focused on education and prevention, early detection and diagnosis, and effective treatment and survivorship programs.

"We're excited to add a second MRIdian system to allow greater access to this personalized, precise radiation therapy for more patients in our health system," said Rodney J. Ellis, M.D., Chair of the Department of Radiation Oncology at Penn State Health. "MRIdian will be part of our standard of care for high quality radiation therapy across our healthcare networks and cancer centers. We now have the opportunity to expand our research collaboration with ViewRay and the community of MRIdian users as a leading site on the ViewRay Genitourinary Consortium. We are positioned to execute cutting-edge technical research projects on enhanced imaging techniques and novel clinical work to demonstrate MRIdian's capabilities in addressing the needs of cancer patients."

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

Quest Imaging Solutions provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs

ViewRay is committed to advancing the practice of MR-guided radiation therapy. In service of this goal, the company has established research consortiums where thought leaders can collaborate on treatment strategies and research projects aimed at generating evidence and protocols to assist MRIdian centers in bringing the best possible care to patients.

Unlike conventional radiation therapy systems, MRIdian combines an MRI with a radiation therapy system. Together with other technical innovations, this offers advantages for the delivery of radiotherapy, including the ability to see the target and surrounding tissue during treatment, adapt therapy in real-time to respond to changes in patient anatomy continuous tracking of the target during treatment, and automatic pausing of the radiation if the target moves from the expected location. As a result, the system delivers radiation to the target while protecting the surrounding healthy tissue from damage.

You Must Be Logged In To Post A Comment